Geopolitics Alpha

Theriva Biologics (TOVX): filings, insider buys & geopolitical news

In the last 30 days, Geopolitics Alpha logged 1 item on Theriva Biologics: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 02 Nov 2026: 8-K - Theriva Biologics, Inc. (0000894158) (Filer).

Government contracts

No federal prime contract obligations are matched to Theriva Biologics in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.

TOVX share price, last 12 months

Close $0.16 on Nov 5, 2026, -49.9% since Nov 3, 2025 (range $0.16 to $0.41, daily closes).

What changed for Theriva Biologics (TOVX)

In the last 30 days, Geopolitics Alpha logged 1 item on Theriva Biologics: 0 news stories, 1 SEC filing and 0 fund or insider trade reports. The latest filing was logged 02 Nov 2026: 8-K - Theriva Biologics, Inc. (0000894158) (Filer).

Latest SEC filings

Latest fund & insider buys and sales

None on record yet.

Latest geopolitical & market news

None on record yet.

Congressional trades in TOVX

Trades in TOVX that members of Congress have publicly reported, newest filing first.

No congressional trades are stored for this view yet.

All congressional stock trades →

Geopolitical news for TOVX

Everything on TOVX, newest first

Frequently asked questions

Does Theriva Biologics have government contracts?

No federal prime contract obligations are matched to Theriva Biologics (TOVX) in USAspending.gov for the last five years. Subcontracts are not included.

Where does the contract data come from?

USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.

What geopolitical news affects TOVX?

This page lists every Geopolitics Alpha note that names TOVX as exposed to an event, with the reason it is exposed.

Has Congress traded TOVX?

The table above lists trades in TOVX that members of Congress have publicly reported, with a link to each official filing.

Is this investment advice?

No. We show news, exposure and past price moves. Nothing here is a recommendation.